Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Its mechanism involves recruiting immune cells to injury sites and promoting angiogenesis, making it a valuable component in regenerative medicine
Clinical trials have used doses of 25-30 nmol/kg by IV infusion (Schneider-Helmert et al., 1981Subcutaneous administration and oral intestinal absorption have also been studied
User protocols typically employ 0.25 to 0.5 mg daily via subcutaneous injection near the injured tendon for four to eight weeks
In rare cases, you could experience an allergic reaction or infection
Label vials with date of reconstitution and use by date to track usage
It is derived from the C-terminal end of alpha-melanocyte-stimulating hormone, and it retains the parent molecule anti-inflammatory properties without the melanogenic (skin-darkening) effects
